Stallone D, Stunkard A, Zweiman B, Wadden T, Foster G
Clin Diagn Lab Immunol. 1994; 1(2):202-5.
PMID: 7496946
PMC: 368228.
DOI: 10.1128/cdli.1.2.202-205.1994.
Dent R, Cole P
Thorax. 1981; 36(6):446-51.
PMID: 7314014
PMC: 471531.
DOI: 10.1136/thx.36.6.446.
Brookes G, Clifford P
J R Soc Med. 1981; 74(2):132-9.
PMID: 7205848
PMC: 1438626.
DOI: 10.1177/014107688107400209.
Browne M, Healy T
Ir J Med Sci. 1982; 151(3):75-8.
PMID: 7076457
DOI: 10.1007/BF02940150.
Gautam S, Gautam S, Deodhar S
J Cancer Res Clin Oncol. 1981; 101(3):265-74.
PMID: 6458620
DOI: 10.1007/BF00410112.
Serum immunoglobulins in patients with prostate cancer.
Gursel E, Megalli M, Veenema R
Urol Res. 1973; 1(4):145-8.
PMID: 4789022
DOI: 10.1007/BF00256613.
The effects of surgery on lymphocyte transformation in patients with cancer.
Watkins S
Clin Exp Immunol. 1973; 14(1):69-76.
PMID: 4716104
PMC: 1553846.
Quantitative dinitrochlorobenzene contact sensitization in a normal population.
Catalona W, Taylor P, Chretien P
Clin Exp Immunol. 1972; 12(3):325-33.
PMID: 4642908
PMC: 1553595.
Cellular immunity, peripheral blood lymphocyte count and pathological staging of tumours in the gastrointestinal tract.
Bone G, LAUDER I
Br J Cancer. 1974; 30(3):215-21.
PMID: 4451626
PMC: 2009205.
DOI: 10.1038/bjc.1974.184.
The effect of tumour growth on immune competence. A study of DMBA mammary carcinogenesis in the rat.
Kearney R, Hughes L
Br J Cancer. 1970; 24(2):319-27.
PMID: 4194927
PMC: 2008577.
DOI: 10.1038/bjc.1970.37.
Immunologic studies in patients with malignant melanoma in Uganda.
Ziegler J, Lewis M, Luyombya J, Kiryabwire J
Br J Cancer. 1969; 23(4):729-34.
PMID: 4189449
PMC: 2008492.
DOI: 10.1038/bjc.1969.89.
Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.
Terazawa A, Tanaka N, Senou N, Inoue F, Matsuura H, Gouchi A
Jpn J Surg. 1987; 17(4):236-42.
PMID: 3682431
DOI: 10.1007/BF02470694.
A study of lymphocyte kinetics in nasopharyngeal carcinoma with indium III oxine-labelled lymphocytes.
Cheng P, Shiu W, Leung J, Ho S, Wong K, Metreweli C
Clin Exp Immunol. 1988; 74(3):398-403.
PMID: 3148379
PMC: 1542032.
[Immune status of patients with bronchial cancer].
Aulenbacher P, Manke H, Drings P
Klin Wochenschr. 1987; 65(10):445-52.
PMID: 3037180
DOI: 10.1007/BF01712835.
Distribution of intrapleural and intravenous Corynebacterium parvum in humans; 99mTc-, and 131I-labeled bacteria.
Kaufmann M, Marqverson J, Stanley K, MOURITZEN C
Cancer Immunol Immunother. 1986; 22(1):56-61.
PMID: 3011262
PMC: 11038980.
DOI: 10.1007/BF00205717.
Changes of peripheral T lymphocyte subsets following treatment in patients with bronchogenic carcinoma.
Kim J, Kim S
Korean J Intern Med. 1989; 4(2):101-7.
PMID: 2486841
PMC: 4534986.
DOI: 10.3904/kjim.1989.4.2.101.
Assessment of local cellular immunity in lung cancer by bronchoalveolar lavage.
Lorenz J, Muller-Quernheim J, Dobosznska A, FERLINZ R
Klin Wochenschr. 1990; 68(14):728-34.
PMID: 1975283
DOI: 10.1007/BF01647581.
Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.
Ikeda T, Masuno T, Ogura T, Watanabe M, Shirasaka T, Hara H
Jpn J Cancer Res. 1991; 82(3):332-8.
PMID: 1850726
PMC: 5918405.
DOI: 10.1111/j.1349-7006.1991.tb01850.x.
Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.
Sone S, KUNISHIGE E, Fawzy F, Yanagawa H, Nii A, Maeda K
Jpn J Cancer Res. 1991; 82(6):716-23.
PMID: 1649813
PMC: 5918506.
DOI: 10.1111/j.1349-7006.1991.tb01908.x.
Effect of surgery on tumour-directed leucocyte responses.
Vose B, Moudgil G
Br Med J. 1975; 1(5949):56-8.
PMID: 1109658
PMC: 1672261.
DOI: 10.1136/bmj.1.5949.56.
